Thrombocytopenia Clinical Trials in Wuhan, Hubei
9 recruitingWuhan, Hubei, China
Showing 1–9 of 9 trials
Recruiting
Phase 1
IASO-782 in Autoimmune Hematological Diseases
Autoimmune ThrombocytopeniaWarm Autoimmune Haemolytic Anaemia
Shanghai IASO Biotechnology Co., Ltd16 enrolled2 locationsNCT06534021
Recruiting
Phase 1
Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
Immune Thrombocytopenia
Guangdong Hengrui Pharmaceutical Co., Ltd10 enrolled1 locationNCT07206758
Recruiting
Early Phase 1
Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology6 enrolled2 locationsNCT06519565
Recruiting
Phase 3
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
Primary immune thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.199 enrolled53 locationsNCT06900920
Recruiting
Phase 2
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Phase 1
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Acute Myeloid LeukemiaThrombocytopeniaNeutropenia+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology9 enrolled1 locationNCT06245746
Recruiting
Phase 2
Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP
Primary immune thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology36 enrolled1 locationNCT06686927
Recruiting
Phase 2Phase 3
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital142 enrolled14 locationsNCT06202625
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856